Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis
Journal of Endocrinological Investigation · 2024
DOI: 10.1007/s40618-024-02500-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von Jianglan Long und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Insulin Resistance, Citrulline, Lactobacillus, Probiotics. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Capital's Funds for Health Improvement and Research, the Youth Beijing Scholar.
Abstract (Originalsprache)
AIMS: The role of Lactobacillus murinus as a potential probiotic is being explored. Our objectives were to explore the effects of Lactobacillus murinus on insulin resistance and the underlying mechanism. METHODS: Insulin resistance animal models were applied to study the effect of L. murinus and the underlying mechanism by six weeks of treatment. Metformin was administered in vitro to analyze the growth and metabolites of L. murinus. Serum metabolites were further analyzed after L. murinus administration. The effect of L-citrulline and the underlying mechanism in alleviating insulin resistance were evaluated. RESULTS: L. murinus not only reduced body weight gain and postprandial blood glucose (PBG) but improved impaired glucose tolerance (IGT) and insulin resistance. Moreover, L. murinus inhibited the secretion of pro-inflammatory factors (IL-1β, IL-6 and TNF-α) while promoted the secretion of anti-inflammatory factor (IL-10). Further, L. murinus promoted the expression of carnitine palmitoyl transferase 1 (CPT1) while inhibited phosphoenolpyruvate carboxykinase (PCK) and glucose-6-phosphatase (G6Pase). A total of 147 metabolites of L. murinus were identified, in which the content of L-citrulline increased to 7.94 times after metformin regulation. Further, the serum concentration of L-citrulline significantly increased after L. murinus administration. Similarly, L-citrulline reduced body weight gain and PBG, improved IGT and insulin resistance. Additionally, L-citrulline improved inflammation, promoted CPT1 while inhibited PCK and G6Pase. CONCLUSIONS: L. murinus mediated by L-citrulline alleviated insulin resistance via promoting fatty acid oxidation and inhibiting gluconeogenesis, suggesting that supplementation of L. murinus could be a potential therapeutic approach for type 2 diabetes related to insulin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China. danyan@ccmu.edu.cn.
Förderung
- the National Natural Science Foundation of China
- Capital's Funds for Health Improvement and Research
- the Youth Beijing Scholar
- Capital’s Funds for Health Improvement and Research
Zitieren
APA
Long, J., Shi, Z., Miao, Z., Dong, L., & Yan, D. (2024). Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02500-5
Vancouver
Long J, Shi Z, Miao Z, Dong L, Yan D. Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02500-5
BibTeX
@article{Long2024,
author = {Long, Jianglan and Shi, Zhe and Miao, Zenghui and Dong, Linjie and Yan, Dan},
title = {Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis},
journal = {Journal of Endocrinological Investigation},
year = {2024},
doi = {10.1007/s40618-024-02500-5}
}
EUVIMED